You searched for "intravitreal"
My Top Five: Promising gene therapies for ocular conditions
4 December 2024
| Ameer Khamise
|
EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...
My Top Five: Promising gene therapies for ocular conditions
4 December 2024
| Ameer Khamise
|
EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...
The National Treatment Centre-Highland
8 September 2023
|
National Treatment Centre-Highland, Andy Pyott, Scotland, Eyecare, Raigmore, NHS Highland
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.
Yorkshire Retina Society Winter Meeting 2024
3 December 2024
by Madiah Mahmood, Junior Medical Education Fellow, Bradford Teaching Hospitals and Foundation Trust, UK; Ewan McCallum, Consultant Ophthalmologist, Bradford Teaching Hospitals and Foundation Trust, UK. The Yorkshire Retina Society is one of the largest regional subspecialty societies in the UK,...
Discussing treatment modalities for bilateral wet AMD
1 December 2014
| Marie Tsaloumas, Bushra Mushtaq
|
EYE - Vitreo-Retinal
A 65-year-old lady with bilateral wet AMD and vision of 6/24 comes with an internet search about current therapies. How do you explain the various treatment modalities available? There are two NICE approved treatments for wet age-related macular degeneration (AMD)....
Radiation retinopathy
The authors review the current treatment options for this condition. Radiation retinopathy (RR) occurs as a complication after exposure to any type of radiation (external beam, plaque brachytherapy and stereotactic radiosurgery) in the orbital or adnexal region. These include nasopharyngeal...
New Treatments in Noninfectious Uveitis
As a specialist registrar training in Aberdeen there were two important lessons I learned which have proved to be invaluable over the years for two very different reasons. The first lesson learned was to never underestimate the wind chill factor...
Management of diabetic macular oedema (DMO)
1 February 2018
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
Anti-VEGF therapy, Diabetic macular edema, Steroids
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...
Fingolimod: ocular adverse effects
1 October 2017
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this article the authors review the ocular side-effects of Fingolimod which is an oral immunomodulating drug used in the management of relapsing-remitting multiple sclerosis (RRMS). Fingolimod-associated macular oedema (FAME) is the most common ocular side-effect linked to this drug....
Epiretinal membranes in uveitic macular oedema
1 August 2014
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
Epiretinal membrane (ERM) formation in uveitic macular oedema is a fairly common structural complication of the retina. The authors describe a retrospective case series of 104 eyes of 77 patients with uveitic macular oedema from a tertiary centre. The treatment...
Aflibercept treatment in polypoidal choroidal vasculopathy
1 April 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
The authors present a study to evaluate the anatomical and functional efficacy of aflibercept intravitreal (IVT) as a monotherapy in polypoidal choroidal vasculopathy (PCV) in a Caucasian population treated with initial three-monthly aflibercept IVT, followed by a bimonthly regimen for...
Microvasculature changes of mCNV after ranibizumab treatment using OCTA
4 February 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this study the authors aim to evaluate the vascular changes of myopic choroidal neovascularisation (mCNV) after ranibizumab treatment using optical coherence tomography-angiography (OCTA). The 3×3 OCTA en face images were analysed for the absence / presence of mCNV, CNV...
